KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Net Income: 2011-2024

Historic Net Income for Travere Therapeutics (TVTX) over the last 14 years, with Dec 2024 value amounting to -$915,000.

  • Travere Therapeutics' Net Income rose 25806.00% to $25.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.3 million, marking a year-over-year decrease of 1014.35%. This contributed to the annual value of -$915,000 for FY2024, which is 100.35% down from last year.
  • Latest data reveals that Travere Therapeutics reported Net Income of -$915,000 as of FY2024, which was down 100.35% from $264.9 million recorded in FY2023.
  • Travere Therapeutics' 5-year Net Income high stood at $264.9 million for FY2023, and its period low was -$169.4 million during FY2020.
  • Over the past 3 years, Travere Therapeutics' median Net Income value was $53.0 million (recorded in 2022), while the average stood at $105.7 million.
  • In the last 5 years, Travere Therapeutics' Net Income spiked by 400.01% in 2023 and then crashed by 100.35% in 2024.
  • Travere Therapeutics' Net Income (Yearly) stood at -$169.4 million in 2020, then surged by 121.96% to $37.2 million in 2021, then skyrocketed by 42.43% to $53.0 million in 2022, then skyrocketed by 400.01% to $264.9 million in 2023, then crashed by 100.35% to -$915,000 in 2024.